What is the recommended dosing order for acetylcysteine (Mucomyst) for mucolytic therapy in adults and children, and for acetaminophen overdose?

Acetylcysteine (Mucomyst) Dosing for Acetaminophen Overdose

For acetaminophen overdose, administer oral acetylcysteine with a loading dose of 140 mg/kg, followed by 70 mg/kg every 4 hours for 17 additional doses (total 72-hour regimen), starting immediately without waiting for acetaminophen levels if within 24 hours of ingestion. 1

Immediate Management Protocol

Initial Steps (Do Not Delay Treatment)

• Initiate acetylcysteine immediately if ≤24 hours have elapsed from reported ingestion, regardless of reported quantity, without awaiting acetaminophen levels 1
• Perform gastric decontamination first: gastric lavage or syrup of ipecac (15 mL for children up to age 12,30 mL for adolescents/adults) 1
• If activated charcoal was given, perform lavage before acetylcysteine administration, as charcoal adsorbs acetylcysteine and reduces effectiveness 1

Standard Oral Dosing Regimen

Loading dose: 140 mg/kg orally 1, 2

Maintenance doses: 70 mg/kg every 4 hours for 17 additional doses (total 18 doses over 72 hours) 1, 2

• Preparation: Dilute 20% solution to 5% concentration using diet cola or other diet soft drinks for oral administration 1
• If using gastric/Miller-Abbott tube, water may be used as diluent 1
• Prepare dilutions freshly and use within 1 hour 1

Vomiting Management

• If patient vomits any dose within 1 hour of administration, repeat that dose 1
• For persistent vomiting preventing oral retention, administer via duodenal intubation 1

Risk Stratification Using Rumack-Matthew Nomogram

When to Use the Nomogram

• Applicable for: Single acute ingestion with known time, acetaminophen level drawn 4-24 hours post-ingestion 3
• Not applicable for: Delayed presentation (>24 hours), unknown time/duration, extended-release formulations, repeated supratherapeutic ingestions 3

Treatment Decisions Based on Nomogram

Level B Recommendation: Administer NAC to patients with possible or probable risk per nomogram to reduce severe hepatotoxicity and mortality, ideally within 8-10 hours post-ingestion 3

Level B Recommendation: Do NOT administer NAC to patients with no risk per nomogram 3

Timing and Efficacy

Critical Time Windows

• 0-8 hours: NAC is protective regardless of initial acetaminophen concentration 2
• 8-10 hours: Hepatotoxicity develops in only 6.1% of at-risk patients when treated within this window 2
• 10-16 hours: Efficacy decreases but treatment still beneficial 2
• 16-24 hours: Hepatotoxicity rate increases to 26.4-41% in at-risk patients, but still superior to no treatment 3, 2
• Beyond 24 hours: Treatment still indicated based on clinical judgment 2

No deaths occurred among patients when NAC was begun within 16 hours of ingestion 2

Special Populations and Situations

Repeated Supratherapeutic Ingestions

• Definition: Multiple ingestions over >8 hours totaling >4 g per 24 hours 3
• ED referral thresholds: ≥10 g or 200 mg/kg (whichever less) in single 24-hour period, OR ≥6 g or 150 mg/kg per 24 hours for ≥48 hours 3
• High-risk patients (isoniazid use, prolonged fasting): Lower threshold to 4 g or 100 mg/kg 3
• These patients have worse prognosis than acute overdose and cannot be risk-stratified with nomogram 3

Patients >100 kg

• Capped dosing (maximum dose based on 100 kg) shows no difference in hepatic injury compared to weight-based dosing 4
• Capped regimen results in lower cumulative dose (285.2 vs 304.6 mg/kg) and reduced cost without compromising efficacy 4

Pediatric Considerations

• Same mg/kg dosing applies 1
• Consider 0.45% saline plus 5% dextrose as diluent to prevent hyponatremia with IV formulations 5

Monitoring Requirements

Baseline Laboratory Studies

Draw before treatment: 1

• Acetaminophen level (for risk stratification)
• AST, ALT, bilirubin
• Prothrombin time
• Creatinine, BUN
• Blood glucose, electrolytes

Serial Monitoring

• Repeat AST, ALT, bilirubin, PT, creatinine, BUN, glucose, electrolytes daily if acetaminophen level is in potentially toxic range 1

Alternative Formulations and Routes

Intravenous vs Oral

• Oral and IV acetylcysteine are equally effective when given within 8-10 hours 6
• Oral route preferred for patients with asthma or atopic histories due to lower anaphylactoid reaction rates (minimal with oral vs 3-6% with IV) 6
• IV route indicated when: treatment >10 hours post-ingestion, contraindications to oral therapy, or persistent vomiting despite interventions 6

Two-Bag IV Regimen (Alternative)

Recent guidelines recommend: 200 mg/kg over 4 hours, then 100 mg/kg over 16 hours—similar efficacy with significantly reduced adverse reactions compared to three-bag regimen 7

Common Pitfalls

• Do not wait for acetaminophen levels before initiating treatment if within 24 hours of ingestion 1
• Do not give activated charcoal after acetylcysteine administration, as it reduces antidote effectiveness 1
• Do not use nomogram for extended-release, repeated supratherapeutic, or unknown-time ingestions 3
• Recognize that hepatotoxicity definitions vary: any AST elevation = hepatotoxicity; AST >1,000 IU/L = severe hepatotoxicity 3

Adverse Effects

• Nausea, vomiting, and gastrointestinal symptoms are common with large oral doses 1
• Rare: rash with or without mild fever, generalized urticaria 1
• If severe allergic symptoms occur, discontinue only if not deemed essential and symptoms cannot be controlled 1